If I'd bought $5,000 of NIB shares 5 years ago, here's how much I'd have now!

Atop the capital gains, NIB shares have also delivered two annual dividends over the past five years.

| More on:
Stethoscope with a piggy bank and hundred dollar notes.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

NIB Holdings Ltd (ASX: NHF) shares aren't joining in the broader market rally today.

The S&P/ASX 200 Index (ASX: XJO) is up 1% in early afternoon trade on Friday, while shares in the ASX 200 private health insurer are down 0.5% to $7.43 apiece.

That sees the stock down 16% since hitting fresh all-time closing highs of $8.85 on 21 June this year.

Still, you're unlikely to hear longer-term investors complaining about their returns.

If I'd bought $5,000 of NIB shares five years ago, here's how much I'd have today.

NIB shares outperform the ASX 200 over the long-run

Over the past five years the ASX 200 has gained a very respectable 36.3%.

But the health insurer's stock has outpaced those gains.

Five years ago, I could have bought NIB shares for $4.98 apiece. Meaning my $5,000 would have seen me snap up 1,004 shares, with a bit of pocket change left over.

Today those shares are swapping hands for $7.43, up 49.2%.

If I were to sell my stock today then, I'd get $7,459.72. Or a very tidy $2,459.72 in profit on my $5,000 investment. (Excluding potential brokerage fees.)

But wait. There's more.

Don't forget the dividends!

Atop the capital gains, NIB shares have also delivered two fully franked dividends for every one of the past five years. The health insurer's stock currently trades on a trailing dividend yield of 3.8%.

As for the past five years, the company has paid out a total of $1.11 in dividends.

Assuming I spent that dividend income as it came in, rather than reinvesting, then we can add that to the current share price.

This then works out to an accumulated value of $8.54 per NIB share, with some potential tax benefits from those franking credits.

That would make my 1,004 shares worth $8,574.16 today, all from my original $5,000 investment five years ago.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended NIB Holdings. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Male doctor in a lab coat working at laptop looking serious.
Healthcare Shares

This bombshell for ASX healthcare shares could hit 6 million Australians

This could have a large impact.

Read more »

Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
Healthcare Shares

2 ASX healthcare shares having a stellar run today

The ASX healthcare sector is down today but these two stocks are bucking the trend.

Read more »

A company manager presents the ASX company earnings report to shareholders at an AGM.
Healthcare Shares

Why this $13 billion ASX 200 healthcare stock is surging today

A change in sentiment for the healthcare player.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

This ASX 200 stock hit a 52-week low and a top broker thinks it can rebound

Patient investors may see this stock make a pleasing recovery.

Read more »

A couple smile as they look at a pregnancy test.
Healthcare Shares

Why this sold-off ASX healthcare share could be an exciting dividend buy

This could be a healthy stock for dividends.

Read more »

a smiling woman sits at her computer at home with a coffee alongside her, as if pleased with her investments.
Healthcare Shares

Is CSL the best ASX 100 share to buy now?

Bell Potter has good things to say about this blue chip star.

Read more »

Scientists in a laboratory look at a computer screen with anticipation on their faces representing a potential change in the performance of ASX biotech shares in FY23
Healthcare Shares

Down 10% in a month, are CSL shares feeling the sting of a potential disruption?

Brokers are still bullish.

Read more »

One girl leapfrogs over her friend's back.
Healthcare Shares

Doubled in a year! Does this booming ASX share have another 24% upside?

Let's take a look.

Read more »